SCHEMBL4336619

SCHEMBL4336619

CC(C)OC(Cc1cccc(NC(=O)COc2ccc(C(C)(C)C)cc2)c1)C(=O)O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 1/20 0.61
EPAS1 Q99814 1/20 0.61
SMN1; SMN2 Q16637 1/20 0.53
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
ALDH1A1 P00352 1/20 0.52
LMNA P02545 1/20 0.52
ROCK2 O75116 1/20 0.49
ROCK1 Q13464 1/20 0.49
POLB P06746 2/20 0.48
GAA P10253 1/20 0.48
CYP2C19 P33261 1/20 0.48
PPARG P37231 1/20 0.48
PPARD Q03181 1/20 0.48
PPARA Q07869 1/20 0.48
HCAR2 Q8TDS4 1/20 0.47
MDH1 P40925 1/20 0.47
MDH2 P40926 1/20 0.47
NR1H4 Q96RI1 1/20 0.47
HPGD P15428 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4335055 0.91 SMN1; SMN2 (0.52) HIF1AEPAS1SMN1; SMN2LMNAPPARG
SCHEMBL4328787 0.89 SMN1; SMN2 (0.57) HIF1AEPAS1SMN1; SMN2MEN1KMT2A
SCHEMBL4328049 0.84 ALDH1A1 (0.48) HIF1AEPAS1SMN1; SMN2MEN1KMT2A
SCHEMBL13819766 0.82 PPARA (0.58) PPARGPPARDPPARA
SCHEMBL4329938 0.82 KMT2A (0.52) HIF1AEPAS1SMN1; SMN2MEN1KMT2A
SCHEMBL4335117 0.81 PPARG (0.52) MEN1KMT2AALDH1A1LMNAPOLB
SCHEMBL4328240 0.81 NR1H4 (0.44) HIF1AEPAS1SMN1; SMN2LMNAPPARG
SCHEMBL4333407 0.81 PPARA (0.47) HIF1AEPAS1SMN1; SMN2MEN1KMT2A
SCHEMBL4337925 0.79 PPARG (0.50) MEN1KMT2AALDH1A1LMNAPPARG
SCHEMBL4348598 0.78 PPARG (0.49) MEN1KMT2AALDH1A1LMNAPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-20040102634-A1 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-05-27 US disclosed
EP-1380562-A1 CARBOXYLIC ACID DERIVATIVE AND SALT THEREOF Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102634-A1 Carboxylic acid derivative and salt thereof GPR119, IRS1, SLC5A1 HIF1A 447/4885EPAS1 1585/4885SMN1; SMN2 3054/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.